Probiotics and Prebiotics in Clinical Nutrition

Date: April 22, 2011
Pages: 132
Price:
US$ 4,795.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PFB7A98ECDFEN
Leaflet:

Download PDF Leaflet

Probiotics and Prebiotics in Clinical Nutrition
Price
Global License: US$ 17,985.00


Introduction

Overall sales of clinical nutrition products are rising with an aging population in the US and EU as well as rising incidence of illnesses and conditions that require clinical nutrition. But sales of clinical nutrition products containing probiotics and prebiotics are outpacing sales of conventional clinical nutrition products, opening up a new market that is dominated by a handful of players.

Features and benefits
  • Understand the clinical nutrition market and broad trends affecting product development and usage.
  • Analyze the unmet need for pro/prebiotic clinical nutrition products and what is the supporting clinical data for product benefits?
  • Identify the key players in the pro/prebiotic clinical nutrition market and the leading products in the market.
  • Forecast the growth of the pro/prebiotic clinical nutrition market by users and product sales in the EU and the US.
  • Assess the future of probiotics and prebiotics in clinical nutrition and the potential product development opportunities.
Highlights

Nearly all of the major manufacturers of enteral nutrition products – Abbott Nutrition, Danone, Fresenius Kabi and Nestlé – are currently working to expand their offerings of products containing probiotics and prebiotics. Currently, several clinical nutrition products are formulated with prebiotics and one major product contains probiotics.

Several special patient populations are especially good candidates for clinical nutrition products containing probtiotics and/or prebiotics as they have specific and/or greater nutritional needs than non-elderly adults. They include the elderly, patients with compromised gastrointestinal systems, the critically ill and infants.

Although there is interest and activity in the development of enteral nutrition products containing probiotics, a lack of basic research establishing the clinical performance of probiotics in enteral nutrition patients is limiting further new product activity.

Your key questions answered
  • Why are clinical nutrition products now incorporating probiotic and prebiotic ingredients? What types products are most amenable to reformulation?
  • What benefits can probiotic and prebiotic ingredients provide in clinical nutrition products that is not otherwise available?
  • What clinical nutrition products currently contain probiotic and prebiotic ingredients?
  • Which patient groups/market segments are most attractive for these products?
  • What is the forecast growth of clinical nutrition products containing probiotics and prebiotics and what are the drivers/inhibitors of R&D?

Executive Summary
  Introduction to clinical nutrition
  Probiotics and their role in healthcare
  Usage of probiotics and prebiotics in clinical nutrition
  Activities of the major players in probiotics and prebiotics
About the author
  Disclaimer
Introduction to clinical nutrition
  Summary
  Introduction
  Major types of clinical nutrition
    Enteral nutrition
    Parenteral nutrition
    Infant nutrition
  Patient populations
    Cancer patients
    Gastrointestinal disease patients
    AIDS patients
    Patients with neuromuscular conditions
    Malnutrition patients
    Other clinical nutrition patients
  Environments for clinical nutrition
    Inpatient environments
    Outpatient environments
  Regulation of clinical nutrition products
    US
    EU
  Insurance coverage
    EU
  User populations
  Conclusions
The evolving role of probiotics in healthcare
  Summary
  Introduction
    Probiotics
    Prebiotics
    Synbiotics
  Factors affecting probiotic levels in the human body
    Declining levels of probiotics in food
  Types of probiotic organisms
  Safety issues
    Probiotics
    Prebiotics
  Benefits of probiotics and prebiotics
    Anxiety
    Colon cancer
    Diarrhea
    Gastrointestinal disease and diarrhea
    Helicobacter pylori
    Hypertension
    Immune system function
    Lactose intolerance
    Mineral absorption
    Urinary tract infections
    Yeast infections
  Disadvantages of probiotics
    Probiotics
    Prebiotics
  Patent issues
  Regulation of probiotic and prebiotic products
    US
    EU
  Other industry issues
    Standards
    Testing protocols
    Consumers’ ability to self-diagnose
  Current products
    Probiotics
    Prebiotics
  User populations
    Probiotics
    Prebiotics
  Conclusions
Usage of probiotics and prebiotics in clinical nutrition
  Summary
  Introduction
  Special populations
    The elderly
    Patients with compromised gastrointestinal systems
    The critically ill
    Infants
  Safety issues
  Current products
  Products under development
    Parenteral nutrition
    Infant nutrition
  Sales forecasts, 2010 - 2015
    Total probiotic supplement sales by region, 2010 - 2015
    Total prebiotic supplement sales by region, 2010–2015
    Sales of clinical nutrition products containing probiotics, 2010–2015
    Sales of clinical nutrition products containing prebiotics, 2010 - 2015
  Conclusions
Activities of the major players in probiotic and prebiotic clinical nutrition products
  Summary
  Introduction
  Leading suppliers of clinical nutrition products
    Abbott Laboratories
    B. Braun
    Danone
    Fresenius Kabi
    Nestlé
    Pfizer
  The future of probiotics and prebiotics in clinical nutrition
  Conclusions
Appendix
  Scope
  Methodology
    Secondary research
  Glossary/Abbreviations
  Bibliography/References

COMPANIES MENTIONED

Abbott Laboratories, B. Braun, Danone, Fresenius Kabi, Nestlé, Pfizer
Skip to top


Ask Your Question

Probiotics and Prebiotics in Clinical Nutrition
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: